Clinical characteristics and outcomes of PTLD following intestinal transplantation
- 11 June 2018
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 32 (8) , e13313
Abstract
Post‐transplant lymphoproliferative disease (PTLD) has the highest incidence following intestinal transplantation (ITx). Our center has seen a recent increase in PTLD. Our aim was to review a single‐center PTLD experience with a focus on clinical characteristics and outcomes. We completed a retrospective review of biopsy‐proven PTLD cases using a prospectively maintained database of 115 ITx recipients transplanted between 1991 and 2014. Nineteen (17%) ITx recipients developed 25 PTLD cases during a median follow‐up time of 6.4 (1.6‐14.6) years. The incidence of early PTLD was 6% (n = 7). There was a trend toward increased risk of PTLD in children compared with adults (P = .11) and a significantly increased risk of PTLD in re‐ITx compared with primary ITx recipients (P = .03). Most PTLD cases were diagnosed between 2010 and 2014 (n = 14). All early PTLD cases were EBV+ on in situ hybridization. Overall graft and patient survival are 68% and 74%, respectively. Second episodes of PTLD were diagnosed in 43% of surviving pediatric patients. Our program has a low incidence of early PTLD with overall excellent graft and patient survival following diagnosis. However, we have also seen a rising incidence of late PTLD. The cause of the increase is unknown as no major changes in immunosuppression protocols have occurred since 1999.Keywords
This publication has 34 references indexed in Scilit:
- Plasmacytoma-like post-transplant lymphoproliferative disorder seen in pediatric combined liver and intestinal transplant recipientsPediatric Blood & Cancer, 2013
- Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative DisorderAmerican Journal of Transplantation, 2013
- Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 casesHaematologica, 2011
- Pretransplant Predictors of Survival After Intestinal Transplantation: Analysis of a Single-Center Experience of More Than 100 TransplantsTransplantation, 2010
- Second Neoplasms in Survivors of Childhood Cancer: Findings From the Childhood Cancer Survivor Study CohortJournal of Clinical Oncology, 2009
- Immune surveillance of tumorsJournal of Clinical Investigation, 2007
- Post‐transplant multiple myeloma in a pediatric renal transplant patientPediatric Blood & Cancer, 2005
- 2003 Report of the Intestine Transplant RegistryAnnals of Surgery, 2005
- EPSTEIN-BARR VIRUS-NEGATIVE LYMPHOPROLIFERATIVE DISORDERS IN LONG-TERM SURVIVORS AFTER HEART, KIDNEY, AND LIVER TRANSPLANT1Transplantation, 2000
- Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations 1 1This study was supported in part by Project Grant No. DK 29661 from the National Institutes of Health, Bethesda, MD.Journal of the American College of Surgeons, 1998